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Upon intracarotid administration of ammonia to cats, there is
a significant increase of cerebral glutamine without a corresponding decrease in the level of cerebral glutamic acid (3). Similar
observations in dogs have been reported by others (4). Since the
supply of glutamic acid from the circulating blood is insufficient
for the formation of the additional amount of glutamine, the dicarboxylic acid has to be synthesized in the brain.1 The continuous utilization of a-ketoglutarate for this purpose would
rapidly deplete the citric acid cycle of its intermediates unless
they can be replenished by C02 fixation. Therefore, the occurrence of significant C02 fixation in brain in vivo was assumed (I,
2). Such an assumption seemed particularly justified, since carbon dioxide fixation had been demonstrated in the isolated retina
10 years ago (5), and the presence of the malic enzyme has also
been shown in brain tissue (6).
We wish to present experiments in which NaHC140 8 was administered by intracarotid infusion to cats with and without
ammonia; the results show a significant fixation of C02into amino
acids by the cerebral cortex in vivo.
EXPERIMENTAL PROCEDURE

General Procedures and NIaterials-The cats were prepared as
described previously (7), and glutamine, glutamic and aspartic
acids, ABA,2 and GSH were isolated from cerebral cortex, liver,
and blood by the methods described in the preceding paper (3).
Sodium bicarbonate-C14 solutions were made up in 0.9% sodium chloride solution with or without N 15-ammonium acetate
(see legends to tables). Sodium bicarbonate-C14 , DL-glutamic
acid-l-C14 , DL-aspartic acid-4-C 14, and standard benzoic acid-C 14
were obtained from New England Nuclear Corporation, \.Valtham, Massachusetts.
The isolated samples of ABA were of low specific activity and
contained large amounts of salt; therefore, these samples were
desalted (8), and the ABA content was redetermined by the
hydroxamate procedure (9) before counting.

* Preliminary reports have been published (1, 2). This work
was supported in part by grants from the National Institute of
Neurological Diseases and Blindness (Grants B-226 and B-557),
National Institutes of Health, United States Public Health
Service, and from the Supreme Council, Thirty-third Degree
Scottish Rite Masons of the Northern Jurisdiction, United States
of America; by a contract between the Office of Naval Research
and the New York State Psychiatric Institute; and by a contract
between the United States Air Force Office of Scientific Research
and the Research Foundation for Mental Hygiene, Inc.
t Fellow of The Rockefeller Foundation.
1
In this paper, "brain" is used synonymously with cerebral
cortex.
2
The abbreviation used is: ABA, 'Y-aminobutvric acid.

The radioactivity of the samples was measured with a NuclearChicago model D-47 thin-window gas flow counter. Aliquots of
the various fractions were pipetted on to weighed stainless steel
planchets (1.25 inches in diameter) and dried under an infrared
lamp and reweighed. The weight of the sample was used to
apply self-absorption corrections. Samples weighing less than
0.1 mg did not require any correction.
Decarboxylation of L-Glutamic Acid-Glutamic acid fractions
obtained from Dowex 1 (AG-1) columns were evaporated to dryness in a rotary flash evaporator and taken up in a measured volume of water (usually 1.2 ml). An aliquot (0.5 ml) was placed
in a double side-armed Warburg flask and decarboxylated by the
procedure of Gale (10) with Escherichia coli ATCC 11246 (Worthington Biochemical Corporation). The side arm containing the
enzyme suspension was stoppered, and the empty side arm was
closed with a gassing tube, which was sealed with a rubber vial
cap. vVhen C02 release had ceased and the pressure was recorded, the C02 was absorbed into 0.2 ml of Hyamine (Packard
Instrument Company), which was injected by syringe through
the vial cap into the empty side arm. Shaking was continued
until the manometer had come to equilibrium (approximately 90
minutes). The flasks were opened, and the Hyamine was transferred to a 20-ml Crystallite vial; the side arm was washed with
four 0.5-ml portions of toluene, which were added to the counting
vial. Toluene (10 ml) containing 0.4% diphenyloxazole and
0.01% p-bis-2-(5-phenyloxazolyl)benzene were added.
The samples were counted in a Packard Tri-Carb liquid scintillation counter. The total radioactivity of the glutamic acid
was determined by counting 0.05-ml aliquots of the initial solution in 10 ml of toluene containing diphenyloxazole and p-bis-2(5-phenyloxazolyl)benzene, and in addition 2 ml of ethanol.
These counts were corrected for que.r1ching by use of benzoic
acid-C 14 as an internal standard. Since the glutamic ar:d aspartic acids (see below) were counted by both methods, the
radioactivity of the C02 could be related to that of the compounds counted by the gas flow counter.
ABA resulting from the decarboxylation of the glutamic acid
was isolated as follows. To the main compartment of the Warburg flask, which contained 2 ml of solution, was added 0.2 ml
of 50% trichloroacetic acid; 2 ml were removed and centrifuged
at approximately 30,000 x g. The supernatant fluid was adjusted to pH 7.0 and was used for the isolation (3) and counting
of the ABA.
When nL-glutamic acid-l-C14 was carried through the above
decarboxylation procedure, 49% of the radioactivity was found
in the C02, and the specific activity of the resultant ABA accounted for less than 0.1% of the radioactivity of the L-glutamic
acid in the sample.
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Decarboxylation of L- Aspartic Acid-Tissue aspartic acid was
decarboxylated by methods similar to those used for glutamic
acid, except for the enzyme preparation and the incubation conditions, which are those of Krebs and Bellamy (11). The organism used, N acardia globerula 13130, (American Type Culture
Collection), was transferred to new medium at intervals of not
longer than 5 days. This organism decarboxylates aspartic acid
to produce C02 and a -alanine (12) . Only 10 % of the Qco2
values reported (11) was obtained with this culture, but our
values were close to those obtained by Crawford (12).
The solution from the main compartment of the Warburg flask
was treated similarly to the decarboxylated glutamic acid (see
above) and placed on a column of Dowex 1. The fraction containing the neutral amino acids was counted to determine the C14
activity remaining in the alanine. The validity of tbis method
was checked with aspartic acid-4-C 14•

I
C14 incorporation into blood, brain, and liver amino acids
during ]'{aHC14 0 a infusion
In each experiment, 650 JJ.C of N aHC 140 3 (9 .56 mg) were infused
over 25 minutes. In Experiment 9, the respiratory rate was
slowed down.
TABLE

Experiment No.

9*

Brain

Glutamine
Glut amic acid
Aspartic acid

0.13
0.06
0.01

390
260
400

ABA

lOt

..

Blood

Liver

c. p.m./ p.mole/ c.p.m./
p.mole/g c.p.m.j
JJ.t11Fole ,.,.mole/ g ,.,.mole
,.,.mole
g

RESULTS AND DISCUSSION

In both experiments in which sodium bicarbonate-C14 was adtninistered to cats by intracarotid infusion, the specific activities
of the compounds isolated from brain cortex are equal to or bigher
than those obtained from blood (Table I) . In previous papers
(3, 13), it has been shown that blood glutamic acid and glutamine
exchange with the respective cerebral metabolites despite an insignificant or small net uptake by the brain; however, the specific
activities of the cerebral amino acids stay far below the blood
amino acids within the experimental period. Hence, the fixation
of carbon dioxide into glutamic and aspartic acids as well as glutamine must have occurred in the cerebral tissue at an appreciable rate. The highest specific activity a1nong the brain metabolites was found in aspartic acid. It is, therefore, probable that
carbon dioxide fixation occurs by condensation with pyruvate or
phosphoenolpyruvate. The data suggest that the mechanism
for carbon dioxide fixation in brain is analogous to that in liver.
Free ABA isolated from brain had 5 % or less of the specific
activity of cerebral glutamic acid (Tables I and II) . In addition, upon decarboxylation of the cerebral glutamic acid and
glutamine, 95 % or more of the C14 activity was found in the
a-carboxyl group of the glutamic acid moiety. Since C-1 of
a-ketoglutarate labeled by carbon dioxide fixation would be lost
by decarboxylation, these findings are also in accord with current
concepts of carbon dioxide fixation and the operation of the citric
acid cycle (14) .
\Vhen, simultaneously with radioactive bicarbonate, ammonium acetate was administered by intracarotid infusion, there
was an increase of specific activity of glutamine relative to that
of aspartic acid (cf. Tables I and II).
The two experiments given in Table II differ by the length of
the period of infusion and by the amount of labeled bicarbonate
administered. Since the glutamine level in brain increases
under these conditions of ammonia infusion, the data i,ndicate
that oxaloacetate is being utilized for the synthesis of a-ketoglutarate, glutamate, and glutamine at a faster rate than it is
converted to aspartic acid. The shift of the 0 14 labeling pattern
from aspartic acid toward glutamine in brain during ammonia
infusion also can be seen when the balance sheet of the distribution of the fixed C14 is considered (Table III). Thus, in Experiments 9 and 10, in which no ammonia was given, aspartic acid
contained 28 and 30 % of the radioactivity in brain, whereas
glutamine contained 9 and 19 % of the C14 , respectively. In
Experiments 6 and 7 (Table III), in which ammonia was infused,
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GSH (glutamic
acid)

0.6

Glutamine
Glutan1ic acid
Aspartic acid

0.2
0.07
0.02

210
380
340

ABA
GSH (glutamic
acid)

(3 )

0.9

7.3
10.6
3.1
1.7
2.1

500
360
1800

5 .7

11.4
2.9
1.8
1.8

1.8
2.0
0.8

1800
1980
5720

39

4.7

80

350
360
2200
19
36

1.8
0.8
0.9

780
860
960

6.3

84

(O)t

*Weight of cat = 2.4 kg.
t Weight of cat = 3.2 kg.
~Parentheses indicate measurement at the limit of the sensi tivity of the counter.
II
C14 incorporation into blood, btain, and liver amino acids
du1·ing N 15 -arnmonium acetate and l\TaHC140 3 infusion
Experiments 6 and 7 are the ones described in the previout'
paper (3), Table I, Experiments 6 and 7. Experhnent 6: 20
mmoles of N 15 -ammonium acetate (99.6 atom % excess) and 63
!J.C of NaHC 14 0 3 (3 .25 me per mmole) were infused into a 3.7-kg
cat over 20 minutes. Experiment 7: 25 mmoles of NtLammonium
acetate (99.6 atom % excess) and 650 J.LC of NaHC 140 3 (3.25 me
per mmole) were infused into a 2.6-kg cat over 25 n1inutes.
TABLE

Experiment No.

Blood

Liver

Brain
bo

p.m./ wnolesj c. p.m./
JJ.mole/ g c.,.,.mole
g
,.,.mole

.........
...,

....
~

<:::.

~

c.p.m. /
,.,.mole

:t

6

7

Glutamine
Glutamic acid
Aspartic acid
ABA
GSH (glutamic
acid)

0.43
0.09
0.05

Glutamine
Glutamic acid
Aspartic acid

0.3
0.09
0.04

ABA
GSH(glutamic
acid)

14
98
270

9.6
9.1

48

2.1

70
(0)*
(3) 4.8

1.3
1.8

180
208
148

8.2
8.4
2 .7
1.7
1.9

19

830
290
370

1.3
2.7
4.0

49
250
81-!
1-!

0.9
1.3
0.6

325
660

1340

3.6

40

(8)

17

* Parentheses indicate measurement at the limit of the sensi tivity of t he counter.

aspartic acid contained 6 and 11 % of the label, respectively, and
glutamine had 35 and 38 % of the C14 activity found in brain.
The fact that the specific activity of cerebral glutamine is
equal to or higher than that of glutamic acid in all four experi-
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III
Relative distribution of C14 in brain amino acids

TABLE

TABLE

The calculations are based on the data in Tables I and II. The
counts per minute per g of tissue were obtained by counting
directly an aliquot of the trichloroacetic acid extract of the
tissues.

Decarboxylation of aspartic acid (brain)
Data of Experiment 9 are presented here.
I

Tissue

Experi- c.p.m. per
ment g of tissue
No.

Trichloroacetic acid
extract . ..
Glutamine . .. .
Glutamic acid
Aspartic acid.

9

ABA ........ .
(gluGSH
tamic
acid) ... ..
Total ... . .. .
Trichloroacetic acid
extract ...
Glutamine . . . .
Olutamic acid
Aspartic acid .
ABA . .. .. . .. .

(gluGSH
tamic
acid) . ....
Total . . .... .

* Parentheses

10

19,700
3,650
3,816
5,580
(0)*

Nt s-arnmonium acetate and

NaHCt40a

Per cent Experi- c.p.m. per
of total ment ~o. g of tissue
counts

100
18.6
19.5
28.4

82

0.4
66.9

21,200
1,995
4,100
6,380
63

100
9.4
19.4
30.2
0.3

34

0.2
59.5

6

1,374
480
170
146
(0)
(6)

7

Per cent
of total
counts

100
35.0
12.4
10.7
(0)

(0.5)
58.6

18,000
6,800
2,400
1,000
14

100
37.8
13.3
5.6
0.1

32

0.2
57.0

indicate measurement at the limit of sensitivity

of the counter.

1nents (Tables I and II) gives further support to the concept of
compartmcntation of glutamic acid and glutamine synthesis in
brain developed in previous papers (3, 13, 15).3
It is interesting to note that the specific activity of liver glutamine is close to that of liver glutamic acid in animals that did
not receive ammonia (Table I). However, in animals receiving
ammonia, the specific activity of liver glutamine was only 20 to
50 % of that found in liver glutamic acid. This suggests that in
liver the compartmentation of glutamine synthesis also exists
3

Aspartic acid

C02

Per cent
of activity
in C02

c.p.m.fp.mole c.p.m.jp.mole

During infusion of
NaHC1403

IV

It should be noted that the specific activities of glutamic acid)
glutamine, and aspartic acid of liver are much lower in Experiment
10 than in Experiment 9 (Table I). In addition, the total C 14
activities in blood (36,200 c.p.m. per g of tissue) and liver (67,700
c.p.m. per g) are much higher in Experiment 9 than in Experiment
10 (blood, 12,500 c.p.m. per g of tissue; liver, 33,800 c.p.m. per g of
tissue)) whereas brain shows comparable values of cu activity
in these experiments (Table III). This is probably due to the
facts that the respiratory pump was adjusted to a respiratory
rate decreased by 25% in Experiment 9, and that the cat used in
Experiment 9 weighed 25% less than the one used in Experiment
10. There is little difference between the radioactivity contained
in brain in both of these experiments. This is not surprising,
since this organ was exposed first to the NaHC140 3 -containing
blood, and any small differences in brain size could not influence
the results significantly.

Brain .. ..... . .
Liver . ..... . ..

1800
5270

1140
2630

Alanine

Per cent
of activity
in alanine

c.p.m.jp.mole

63
50

580
2450

32
46

but reverses the pattern of that in brain; viz. the liver pool of
glutamic acid used for glutamine synthesis appears to con1e
mainly from a large tissue pool of this amino acid) which docs not
mix very rapidly with newly synthesized glutamic acid, the
amino group of which is channeled into aspartic acid formation;
these conclusions are in accord with the results of the experiments
in the preceding paper (3).
The radioactivity in blood and liver amino acids accounts for
only a sn1all portion of the total radioactivity in these tissues.
In brain, also) only approximately half of the radioactivity was
recovered in the amino acids analyzed, whereas in the N 15 experiments (3), the isotope content of these compounds accounted for
close to 90 % of the isotope content of the trichloroacetic acid
extract. It is probable that a large portion of the radioactivity
not accounted for in these tissues is present in glucose and
members of the citric acid cycle, since, as known from studies on
liver, this organ incorporates C140 2 rapidly into carbon atoms
3 and 4 of glucose (16, 17).
The aspartic acid of liver and brain in Expcrin1ent 9 was decarboxylated to give the ~].. carboxyl group (as carbon dioxide)
and a-alanine (Table IV). In brain, 63 % of the radioactivity
was found in the C02, and 32 % remained in the alanine fraction,
whereas in liver, the counts were almost equally distributed
between the C02 and alanine. This distribution of counts in
aspartic acid supports the operation of the "dicarboxylic acid
shuttle" (18) .
·
The demonstration that brain can fix carbon dioxide to a significant extent raises the question whether ammonia toxicity
can be explained by depletion of the citric acid cycle intermediates of brain (19). Whether or not the rate of carbon dioxide
fixation in brain is sufficient to counteract the drain on citric
acid cycle intermediates cannot be evaluated without data on the
rate of C02 fixation into these intermediates. Work along these
lines is now in progress. In addition, for a better understanding
of the effects of the increased ammonia levels on brain metabolism, the capacity of the glutamine-forming syste1n as well as
the fate of the glutamine synthesized in response to the elevated
ammonia levels will have to be known.
Investigations of cerebral tissue have shown that it contains
all of the enzymatic activities of the major metabolic pathways
found in other organs; the demonstration of a potent carbon
dioxide-fixing mechanism underlines the similarity of brain to
other metabolically highly active tissues, such as liver, and adds
another essential feature to the autonomy of cerebral metabolism.4 On the other hand, the extent and rate of carbon dioxide
4

C02 fixation is not restricted to the mammalian central nervous system. Recent experiments in this laboratory have delnonstrated incorporation of COz into the dicarboxylic amino acids
and into the intermediates of the citric acid cycle in the isolated
lobster nerve (20).
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fixation may introduce another controlling factor in the operation
of the citric acid cycle, a fact of particular significance for
cerebral tissue, in which glucose is the main, if not the sole,
source of energy of metabolism. Our findings also raise the
question whether some effects on nervous tissue of C02 ascribed
to its influence on the physicochemical environment (e.g. pH)
may not be the result of the direct participation of C02 in the
metabolism of the tissue mediated by C02 fixation.
SUMMARY

Carbon dioxide fixation in brain was studied in cats to which
N aHC 14() 3, with and without ammonia, was administered by
intracarotid infusion. Glutamic and aspartic acids, glutamine,
glutathione, and ')'-aminobutyric acid were isolated from blood,
brain, and liver, and their specific activities were determined.
The data indicate a significant incorporation of C02 into the
amino acids of the cerebral cortex, presumably by way of the
citric acid cycle. "\Vithout simultaneous ammonia infusion, the
specific activity of aspartic acid is 3 times that of glutamine,
whereas in the presence of ammonia the ratios of specific activity
of both compounds are closer to unity or reversed. The data
suggest that in the presence of an1monia the oxaloacetic acid is
channeled into glutamine formation. ')'-Aminobutyric acid isolated from the tissue, as well as that obtained after decarboxylation of glutamic acid or glutamine, has less than 5 % of the
counts of the precursor. These findings give additional support
to the assumption that the operation of a C02 fixation mechanism in brain is similar to that in liver. Additional data on the
con1partmentation of glutamic acid and glutamine synthesis are
presented.
The significance of the findings for an interpretation of ammonia metabolism in brain is pointed out.

Acknowledgment-We are highly indebted to Dr. D.P. Purpura
for his essential collaboration in the physiological aspects of
these experiments.
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